within Pharmacolibrary.Drugs.L_AntineoplasticAndImmunomodulatingAgents.L04A_Immunosuppressants.L04AB01_Etanercept;

model Etanercept
  extends Pharmacolibrary.Drugs.ATC.L.L04AB01;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>L04AB01</td></tr><td>route:</td><td>subcutaneous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Etanercept is a recombinant human tumor necrosis factor (TNF) receptor fusion protein that acts as a TNF inhibitor. It is used to reduce the symptoms and progression of autoimmune disorders such as rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, and plaque psoriasis. Etanercept is approved and in clinical use.</p><h4>Pharmacokinetics</h4><p>Reported pharmacokinetic parameters for healthy adults and adults with rheumatoid arthritis receiving standard subcutaneous dosing.</p><h4>References</h4><ol><li><p>Pelechas, E, &amp; Drosos, AA (2019). Etanercept biosimilar SB-4. <i>Expert opinion on biological therapy</i> 19(3) 173–179. DOI:<a href=\"https://doi.org/10.1080/14712598.2019.1566456\">10.1080/14712598.2019.1566456</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/30616405/\">https://pubmed.ncbi.nlm.nih.gov/30616405</a></p></li><li><p>McCormack, PL, &amp; Wellington, K (2004). Etanercept: in ankylosing spondylitis. <i>BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy</i> 18(3) 199–206. DOI:<a href=\"https://doi.org/10.2165/00063030-200418030-00006\">10.2165/00063030-200418030-00006</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/15161337/\">https://pubmed.ncbi.nlm.nih.gov/15161337</a></p></li><li><p>van Bezooijen, JS, et al., &amp; van Gelder, T (2017). Intrapatient Variability in the Pharmacokinetics of Etanercept Maintenance Treatment. <i>Therapeutic drug monitoring</i> 39(4) 333–338. DOI:<a href=\"https://doi.org/10.1097/FTD.0000000000000384\">10.1097/FTD.0000000000000384</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/28691952/\">https://pubmed.ncbi.nlm.nih.gov/28691952</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Etanercept;
